Literature DB >> 15322931

Effect of inappropriate initial empiric antibiotic therapy on outcome of patients with community-acquired intra-abdominal infections requiring surgery.

K Krobot1, D Yin, Q Zhang, S Sen, A Altendorf-Hofmann, J Scheele, W Sendt.   

Abstract

To assess the significance of initial empiric parenteral antibiotic therapy in patients requiring surgery for community-acquired secondary peritonitis, 425 patients hospitalized between January 1999 and September 2001 in 20 clinics across Germany were followed for a total of 6,521 patient days. Perforated appendix (38%), colon (27%), or gastroduodenum (22%) were the most common sites of infection. Escherichia coli was the most common pathogen. A total of 54 (13%) patients received inappropriate initial parenteral therapy not covering all bacteria isolated, or not covering both aerobes and anaerobes in the absence of culture results. Clinical success, predefined as the infection resolving with initial or step-down therapy after primary surgery, was achieved in 322 patients (75.7%; 95% confidence interval (CI), 70.6-81.2). Patients were more likely to have clinical success if initial antibiotic therapy was appropriate (78.6%; 95% CI, 73.6-83.9) rather than inappropriate (53.4%; 95% CI, 41.1-69.3). Patients having clinical success were estimated to stay 13.9 days in hospital (95% CI, 13.1-14.7), while those who had clinical failure stayed 19.8 days (95% CI, 17.3-22.3). In conclusion, appropriateness of initial parenteral antibiotic therapy was a predictor of clinical success, which in turn was associated with length of stay. Copyright 2004 Springer-Verlag

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15322931     DOI: 10.1007/s10096-004-1199-0

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  11 in total

1.  Evaluation of new anti-infective drugs for the treatment of intraabdominal infections. Infectious Diseases Society of America and the Food and Drug Administration.

Authors:  J S Solomkin; D L Hemsell; R Sweet; F Tally; J Bartlett
Journal:  Clin Infect Dis       Date:  1992-11       Impact factor: 9.079

2.  Maximum likelihood estimation of the attributable fraction from logistic models.

Authors:  S Greenland; K Drescher
Journal:  Biometrics       Date:  1993-09       Impact factor: 2.571

3.  The influence of mini-BAL cultures on patient outcomes: implications for the antibiotic management of ventilator-associated pneumonia.

Authors:  M H Kollef; S Ward
Journal:  Chest       Date:  1998-02       Impact factor: 9.410

4.  Community-acquired pneumonia: etiology, epidemiology, and outcome at a teaching hospital in Argentina.

Authors:  C M Luna; A Famiglietti; R Absi; A J Videla; F J Nogueira; A D Fuenzalida; R J Gené
Journal:  Chest       Date:  2000-11       Impact factor: 9.410

5.  Management of intra-abdominal infections. The case for intraoperative cultures and comprehensive broad-spectrum antibiotic coverage. The Canadian Intra-abdominal Infection Study Group.

Authors:  N V Christou; P Turgeon; R Wassef; O Rotstein; J Bohnen; M Potvin
Journal:  Arch Surg       Date:  1996-11

6.  Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia.

Authors:  C M Luna; P Vujacich; M S Niederman; C Vay; C Gherardi; J Matera; E C Jolly
Journal:  Chest       Date:  1997-03       Impact factor: 9.410

7.  Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients.

Authors:  M H Kollef; G Sherman; S Ward; V J Fraser
Journal:  Chest       Date:  1999-02       Impact factor: 9.410

8.  Antibiotic treatment for surgical peritonitis.

Authors:  D M Mosdell; D M Morris; A Voltura; D E Pitcher; M W Twiest; R L Milne; B G Miscall; D E Fry
Journal:  Ann Surg       Date:  1991-11       Impact factor: 12.969

9.  Susceptibility of intra-abdominal isolates at operation: a predictor of postoperative infection.

Authors:  J A Hopkins; J C Lee; S E Wilson
Journal:  Am Surg       Date:  1993-12       Impact factor: 0.688

10.  Guidelines for clinical care: anti-infective agents for intra-abdominal infection. A Surgical Infection Society policy statement.

Authors:  J M Bohnen; J S Solomkin; E P Dellinger; H S Bjornson; C P Page
Journal:  Arch Surg       Date:  1992-01
View more
  27 in total

1.  Prognostic factors in critically ill patients suffering from secondary peritonitis: a retrospective, observational, survival time analysis.

Authors:  Christian P Schneider; Carol Seyboth; Markus Vilsmaier; Helmut Küchenhoff; Benjamin Hofner; Karl-Walter Jauch; Wolfgang H Hartl
Journal:  World J Surg       Date:  2009-01       Impact factor: 3.352

2.  Multicenter study evaluating the role of enterococci in secondary bacterial peritonitis.

Authors:  Emilia Cercenado; Luis Torroba; Rafael Cantón; Luis Martínez-Martínez; Fernando Chaves; Jose Angel García-Rodríguez; Carmen Lopez-Garcia; Lorenzo Aguilar; César García-Rey; Nuria García-Escribano; Emilio Bouza
Journal:  J Clin Microbiol       Date:  2009-11-25       Impact factor: 5.948

3.  Canadian practice guidelines for surgical intra-abdominal infections.

Authors:  Anthony W Chow; Gerald A Evans; Avery B Nathens; Chad G Ball; Glen Hansen; Godfrey Km Harding; Andrew W Kirkpatrick; Karl Weiss; George G Zhanel
Journal:  Can J Infect Dis Med Microbiol       Date:  2010       Impact factor: 2.471

4.  Inappropriate initial treatment of secondary intra-abdominal infections leads to increased risk of clinical failure and costs.

Authors:  Miriam C J M Sturkenboom; Wim G Goettsch; Gino Picelli; Bas in 't Veld; Don D Yin; Romy B de Jong; Peter M N Y H Go; Ron M C Herings
Journal:  Br J Clin Pharmacol       Date:  2005-10       Impact factor: 4.335

Review 5.  [Complicated intra-abdominal infections: pathogens, resistance. Recommendations of the Infectliga on antbiotic therapy].

Authors:  K-F Bodmann
Journal:  Chirurg       Date:  2010-01       Impact factor: 0.955

6.  Risk factors for acquisition of multidrug-resistant bacteria in patients with anastomotic leakage after colorectal cancer surgery.

Authors:  Dae-Sang Lee; Jeong-Am Ryu; Chi Ryang Chung; JeongHoon Yang; Kyeongman Jeon; Gee Young Suh; Woo Yong Lee; Chi-Min Park
Journal:  Int J Colorectal Dis       Date:  2015-03-04       Impact factor: 2.571

7.  Risk factors for multidrug resistant bacteria and optimization of empirical antibiotic therapy in postoperative peritonitis.

Authors:  Pascal Augustin; Nathalie Kermarrec; Claudette Muller-Serieys; Sigismond Lasocki; Denis Chosidow; Jean-Pierre Marmuse; Nadia Valin; Jean-Marie Desmonts; Philippe Montravers
Journal:  Crit Care       Date:  2010-02-15       Impact factor: 9.097

8.  Efficacy and safety of tigecycline monotherapy vs. imipenem/cilastatin in Chinese patients with complicated intra-abdominal infections: a randomized controlled trial.

Authors:  Zhangjing Chen; Jufang Wu; Yingyuan Zhang; Junming Wei; Xisheng Leng; Jianwei Bi; Rong Li; Lunan Yan; Zhiwei Quan; Xiaoping Chen; Yunsong Yu; Zhiyong Wu; Dawei Liu; Xiaochun Ma; Robert Maroko; Angel Cooper
Journal:  BMC Infect Dis       Date:  2010-07-21       Impact factor: 3.090

9.  Characteristics of surgical patients receiving inappropriate empiric antimicrobial therapy.

Authors:  Stephen W Davies; Jimmy T Efird; Christopher A Guidry; Tjasa Hranjec; Rosemarie Metzger; Brian R Swenson; Robert G Sawyer
Journal:  J Trauma Acute Care Surg       Date:  2014-10       Impact factor: 3.313

10.  Does it Matter if we get it right? Impact of appropriateness of empiric antimicrobial therapy among surgical patients.

Authors:  Stephen W Davies; Jimmy T Efird; Christopher A Guidry; Tjasa Hranjec; Rosemarie Metzger; Brian R Swenson; Robert G Sawyer
Journal:  Shock       Date:  2014-09       Impact factor: 3.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.